Exploring the Potential for Graphic Warning Labels to Reduce Intentions to Consume Energy Drinks
Health Promotion Journal of Australia · 2025-04 · 36 (2)
DOI: 10.1002/hpja.70004 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Health Promotion Journal of Australia, online erschienen am 21.02.2025. Verfasst von Xiaole Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Adelaide School of Psychology, Adelaide, Australia. Hauptthemen laut MEDLINE: Intention, Energy Drinks, Product Labeling, Food Labeling. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Policy Centre, South Australian Health and Medical Research Institute, National Health and Medical Research Council, Heart Foundation Future Leader Fellowship for CM.
Abstract (Originalsprache)
Issue Addressed Effective interventions to reduce energy drink (ED) consumption are needed. This study explored the effect of warning labels on intentions to reduce ED consumption, perceived label effectiveness and protection motivation theory (PMT) constructs.
Methods
Australian ED consumers aged 18 to 39 years ( N = 343) participated in an experimental online survey, randomly assigned to view one of three ED warning label conditions (weight gain, cardiac effects, no label—control). Intentions to reduce ED consumption, perceived effectiveness of labels and selected PMT constructs were assessed.
Results
Participants reported moderate‐high awareness of the health effects of consumption (62.68%) and advisory statements on EDs (69.39%), including daily consumption limits (48.40%). EDs were consumed frequently, with 56.26% regular (at least weekly) consumers and most commonly for functional benefits (e.g., alertness). ED warning labels did not have a statistically significant effect on intentions to reduce consumption. The cardiac label performed better than the weight gain label in ‘grabbed attention’ (72.97% vs. 55.66%, p = 0.008), with non‐significant trends ( p > 0.05, absolute differences ≥ 10%) suggesting it was stronger on some other perceived effectiveness measures. Supplementary analyses indicated females in the cardiac condition reported greater intentions to reduce ED consumption than females in the control condition ( p = 0.042).
Conclusions
Graphic warning labels and labels warning of cardiac effects are worthy of further exploration as a potential intervention to reduce ED consumption. So What? Future research should explore the motivations underlying ED consumption and further explore messages that will resonate with consumers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Adelaide School of Psychology, Adelaide, Australia.
- University of Adelaide School of Public Health, Adelaide, Australia.
- Health Policy Centre, South Australian Health and Medical Research Institute, Adelaide, Australia.
ORCID-Profile: Caroline Miller, Rachel Roberts, Kerry Ettridge
Förderung
- Health Policy Centre, South Australian Health and Medical Research Institute
- National Health and Medical Research Council
- Heart Foundation Future Leader Fellowship for CM
- Cancer Council Principal Research Fellowship for CM
Zitieren
APA
Zhu, X., Miller, C., Roberts, R., & Ettridge, K. (2025). Exploring the Potential for Graphic Warning Labels to Reduce Intentions to Consume Energy Drinks. Health Promotion Journal of Australia, 36(2). https://doi.org/10.1002/hpja.70004
Vancouver
Zhu X, Miller C, Roberts R, Ettridge K. Exploring the Potential for Graphic Warning Labels to Reduce Intentions to Consume Energy Drinks. Health Promotion Journal of Australia. 2025;36(2). doi:10.1002/hpja.70004
BibTeX
@article{Zhu2025,
author = {Zhu, Xiaole and Miller, Caroline and Roberts, Rachel and Ettridge, Kerry},
title = {Exploring the Potential for Graphic Warning Labels to Reduce Intentions to Consume Energy Drinks},
journal = {Health Promotion Journal of Australia},
year = {2025},
volume = {36},
number = {2},
doi = {10.1002/hpja.70004}
}
EUVIMED